PITTSBURGH, November, 2013 — Gateway Analytical will be showcasing our pharmaceutical investigations and testing services for pharmaceutical materials characterization, at booth #4213 during 2013 AAPS Annual Meeting & Exposition in San Antonio, Texas. The conference, hosted by the American Association of Pharmaceutical Scientists (AAPS), allows thousands of members of the pharmaceutical science community to gather for the purpose of exchanging knowledge, discussing the latest research and technologies being used and networking with peers as well as other professionals from the pharmaceutical industry.
At the conference, Gateway Analytical will highlight its 20 years of experience in advanced analytical testing services for a wide range of pharmaceutical drug product types. Representatives from Gateway Analytical will discuss the lab’s analytical services offerings – specifically orally inhaled and nasal products, tablets, semi-solids, transdermal drug delivery, pharmaceutical investigations, glass delamination and defect analysis, as well as their consulting services.
“We are very excited to exhibit at the AAPS conference and showcase our expertise to a large group of pharmaceutical scientists,” said David Exline, Senior Vice President at Gateway Analytical. “Our aim is to convey that at the root of our laboratory environment lies a trusted quality system. We are well versed in cGMP and Quality by Design (QbD) processes and procedures to support foreign particulate matter identifications and other pharmaceutical investigation services. Our expertise can help to guide pharmaceutical customers through tough regulatory waters as they develop products.”
Gateway Analytical is a full service FDA registered and inspected laboratory with specialized expertise in state-of-the-art techniques for chemically specific particle sizing and particulate contamination identification. The lab’s accreditations include cGMP-compliant, ISO 9001:2008, 21 CFR parts 210 & 211, 21 CFR part 820, and ICH Q7. By utilizing techniques such as optical and polarized light microscopy, Raman and FTIR spectroscopy, SEM/EDS and Raman, visible fluorescence and NIR chemical imaging, Gateway Analytical’s scientists are able to offer unique forensic-based-testing methods to quickly address pharmaceutical issues such as identifying when and where foreign particulate matter enter a manufacturing process, pinpointing the root cause of product failures or investigating the source of product stains or discoloration.
For more information on Gateway Analytical’s pharmaceutical forensic and investigation services, contact Tracey Safran, Senior Account Manager, at firstname.lastname@example.org or Karen Sutch, Business Development Manager, at email@example.com.
About Gateway Analytical
Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries.
Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.
ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company’s proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.
ChemImage’s headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.